ANI Pharmaceuticals, Inc. Overview
Contact top employees from
ANI Pharmaceuticals, Inc.
Summary
ANI Pharmaceuticals, Inc. is a public company that has been in the industry for 24 years. The company currently specializes in the Pharmaceuticals area. The position of the President & CEO is occupied by Nikhil Lalwani. Its headquarters is located at Baudette, Minnesota, USA. The number of employees ranges from 250 to 500. The annual revenue of ANI Pharmaceuticals, Inc. varies between 100M and 500M. To connect with ANI Pharmaceuticals, Inc. employee register on SignalHire.
ANI Pharmaceuticals, Inc. industries
Pharmaceuticals
Headquarters Location
ANI Pharmaceuticals, Inc. Employees Size
500-1000 employees
Specialties
Hormone Manufacturing and Packaging, Solid Dose Manufacturing and Packaging, Contract Packaging, Liquid Dose Manufacturing and Packaging, Controlled Substances, Rare Disease, Generics, Established Brands, Contract Manufacturing, Oncolytics, Cortrophin
SIC Code
2834
DMA Code
Fargo–moorhead
Founded
2001
Estimated Annual Revenue
$100M - 500M
Operating Status
Independent Company
Contact ANI Pharmaceuticals, Inc.
Organization Website
Social Links
Phone Number
609-632-2776
ANI Pharmaceuticals, Inc. Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 1888 | Public Company | 100K - 9.9M | 40.2B | $6.9M | |
| 1948 | Public Company | 10K - 50K | 16B | $31.1M | |
| 1963 | - | 25 - 100 | 14.9M | $350K | |
| 2009 | Privately Held | 1.0K - 5.0K | 1B | $0 | |
| 1999 | Public Company | 50K - 100K | 29.5B | $0 | |
| 1994 | Public Company | 50K - 100K | 45.6B | $0 | |
| 1996 | Public Company | 100K - 9.9M | 50.4B | $0 | |
| 1876 | Public Company | 10K - 50K | 26.7B | $0 | |
| 1891 | Public Company | 50K - 100K | 50.1B | $0 | |
| 1817 | Public Company | 10K - 50K | 21.6B | $0 | |
| 1988 | Sole Proprietorship | 100 - 250 | 10M | $0 | |
| 1848 | Public Company | 50K - 100K | 55.5B | $0 | |
| 1867 | Public Company | 1.0K - 5.0K | 1.7B | $0 | |
| 1977 | Public Company | 10K - 50K | 1.4B | $0 | |
| 1886 | Public Company | 100K - 9.9M | 89.2B | $0 | |
| 2002 | - | 5000-10000 | - | $- | |
| 1997 | - | 1000-5000 | - | $- | |
| 1954 | - | - | $- | ||
| 1896 | - | 10000+ | - | $- | |
| 1989 | - | 1000-5000 | - | $- |
ANI Pharmaceuticals, Inc. Revenue
Annual Revenue
213.4M
Slight revenue growth in Q4 2020 gave way to a steady decline from Q1 2021 to Q2 2021. The company's quarterly revenue decreased by 4.4M - from 53.0M in Q3 2020 to 48.6M in Q2 2021.ANI Pharmaceuticals, Inc. Employees Turnover 2 quarter 2025
Number of employees switched from or switched to
Total number all of employee turnover
Current employees switched from
1
KPMG
1
Veracity Software Inc
1
Amarin Corporation
1
The College of St. Scholastica
1
Aon
Ex-employees switched to
B
1
Stock Market
B
1
Level 10 Management
B
1
Blueprint Medicines
B
1
NS Pharma, Inc.
B
2
Astellas Pharma
B
1
Hackensack Meridian Health
Number of employees by department
Total number all of employee turnover
Ex-employees positions
In Company
In New Company
Contact top employees from
ANI Pharmaceuticals, Inc.
Morgan Cook
Ophthalmology Account Executive
Debbie Echeverria
Sr National Account Director
Leanna Henderson
Clinical Account Executive
Joe Guardado
Customer Account Executive
Kim Brillhart
Clinical Account Executive - Rare Disease
Richard Cardona
Director of Marketing Operations
Chelsea Ruckdeschel
Opthamology Account Executive - Rare Disease/Retina
Dana Mullen
Clinical Account Executive
Bethany Toner
Field Reimbursement Manager
Elizabeth Larson
Senior Financial Analyst
Nabila Boubsis
Credit Collections Manager
Nakul Vyas
VP, Head of Technology
Millie Reyes
Ophthalmology Account Executive
Lindsay Antoniuc
Talent Acquisition Manager
Brett Snyder
Account Executive
Kaleb Webb
Clinical Account Executive - Rare Disease
Edward DeSimone
Vice President Of Product Development
Kim Mangan
Clinical Account Executive
Sharif Aly
Associate Director, Compliance and Data Operations
Michael Blood
Area Business Manager
Bill Maschmeier
Account Executive
Kenneth Miller
Director, Medical Science Liaison- Program Lead - Neurology
Grace Hsueh
Medical Science Liaison, Associate Director
Eric Ferriere
Ophthalmic Account Executive
Rowena Miller
Ophthalmology Account Executive
Brett Rosenthal
Rare disease ophthalmology accout executive
Marsha Nash
Clinical Account Executive/Rare Disease
